1. "Survivorship Research"
Formats
  1. Journal Article (8899)
  2. Meeting Abstract (5192)
  3. Book Section (571)
  4. Review (357)
  5. Editorial (225)
  6. Research Letter (132)
  7. Conference Paper (104)
  8. Correspondence (91)
  9. Guidelines (85)
  10. Miscellaneous (76)
  11. Book Whole (30)
Groups
  1. Survivorship Research (15762)
  2. Department of Medicine (9201)
  3. Population Sciences Research Program (5670)
  4. Solid Tumor Oncology Division (5183)
  5. Surgery (5130)
  6. Epidemiology and Biostatistics (3598)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (788)
  3. Michael Zelefsky (754)
  4. Sergio Giralt (684)
  5. Mark Robson (676)
  6. Joachim Yahalom (625)

More People

Years
  1. 2025 (231)
  2. 2024 (802)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (930)

More Years

Publications
  1. Journal of Clinical Oncology (1873)
  2. International Journal of Radiation Oncology, Biology, Physics (908)
  3. Blood (685)
  4. Annals of Surgical Oncology (599)
  5. Cancer Research (333)
  6. Cancer (331)

More Publications

Publishers
  1. Elsevier Inc. (2658)
  2. American Society of Clinical Oncology (2019)
  3. Springer (1542)
  4. Wiley Blackwell (806)
  5. Oxford University Press (787)
  6. American Society of Hematology (748)

More Publishers

Results (15762)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Complex association between social support and chemotherapy-related toxicities in older cancer patients
    Meeting Abstract

    Shahrokni, A.; Sun, C.; Tew, W. P.; Mohile, S. G.; Owusu, C.; Klepin, H. D.; Gross, C. P.; Lichtman, S. M.; Gajra, A.; Katheria, V.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Assessing the clinical feasibility of electronic Rapid Fitness Assessment (eRFA): A novel geriatric assessment tool for the oncology setting
    Meeting Abstract

    Shahrokni, A.; Vickers, A. J.; Mahmoudzadeh, S.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Pre-cancer cardiovascular risk factors and anthracycline-related cardiotoxicity among non-Hodgkin lymphoma survivors
    Meeting Abstract

    Salz, T.; Brown, P.; Zabor, E. C.; Dalton, S. O.; Raghunathan, N. J.; Matasar, M. J.; Steingart, R.; Vickers, A. J.; Oeffinger, K. C.; Johansen, C.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Non-randomized phase II study to assess the efficacy of pembrolizumab (Pem) plus radiotherapy (RT) or ablation in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC) patients
    Meeting Abstract

    Segal, N. H.; Kemeny, N. E.; Cercek, A.; Reidy, D. L.; Raasch, P. J.; Warren, P.; Hrabovsky, A. E.; Campbell, N.; Shia, J.; Goodman, K. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Peripheral blood T cell subset phenotype analysis in melanoma patients treated with combination nivolumab + ipilimumab compared to ipilimumab alone
    Meeting Abstract

    Postow, M. A.; Kuk, D.; Adamow, M.; Carrera, C.; Wong, P.; Curran, M. A.; Friedman, C. F.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The role for resection of post-chemotherapy residual liver masses in the management of non-seminomatous germ cell tumor
    Meeting Abstract

    Pietzak, E. J.; Assel, M.; Tennenbaum, D. M.; Becerra, M.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; Carver, B. S.; Sjoberg, D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cancer susceptibility mutations in individuals with breast and ovarian cancer using next-generation sequencing
    Meeting Abstract

    Offit, K.; Schrader, K. A.; Maxwell, K. N.; Vijai, J.; Hart, S.; Thomas, T.; Wubbenhorst, B.; Ravichandran, V.; Moore, R.; Hu, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC)
    Meeting Abstract

    O'Cearbhaill, R. E.; McMeekin, D. S.; Mantia-Smaldone, G.; Gunderson, C.; Sabbatini, P.; Cattaruzza, F.; Fischer, M.; Kapoun, A. M.; Xu, L.; Dupont, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The EMPOWER study: Promoting breast cancer screening-A randomized controlled trial (RCT) in the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Oeffinger, K. C.; Ford, J.; Moskowitz, C. S.; Chou, J. F.; Henderson, T. O.; Hudson, M. M.; Diller, L.; McDonald, A.; Ford, J.; Mubdi, N. Z.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The PRONTO amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 2b study of NEOD001 in previously treated subjects with light chain amyloidosis and persistent cardiac dysfunction
    Meeting Abstract

    Merlini, G.; Liedtke, M.; Landau, H. J.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Schonland, S.; Guthrie, S. D.; Walling, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save